Drug-pricing – medicarereport.org

Health Care Finance Health Care Redesign Part D/Prescription Drugs

This Panel Will Decide Whose Medicine to Make Affordable. Its Choice Will Be Tricky

May 25, 2023May 25, 2023 Eileen Cook 0 Comments Affordable Medicine, Drug-pricing, Healthcare Costs

(By Markian Hawryluk for KFF Health News) Catherine Reitzel’s multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies

FDA Health Care Finance Legislative Update Part D/Prescription Drugs

PBMs, the Brokers Who Control Drug Prices, Finally Get Washington’s Attention

May 11, 2023 Eileen Cook 0 Comments Drug-pricing, Legislation, PBM Industry, pharmaceuticals

(By Arthur Allen for KFF Health News) For two decades, patients and physicians eagerly awaited a lower-cost version of the

Affordable Care Act (ACA) Employer Healthcare Health Care Redesign Health Insurance Legislative Update Part D/Prescription Drugs

How Medicare drug pricing changes could affect commercial plans: 3 things to know

December 15, 2022December 15, 2022 Eileen Cook 0 Comments Drug-pricing, Employer Health Insurance, Higher out-of-pocket expense, Inflation Reduction Act of 2022, medicare

(By Rylee Wilson for Becker’s Hospital Review) The drug-pricing provisions of the Inflation Reduction Act only apply directly to Medicare,